The data of the present study provide new insight about effects of WFS1 on glucose-insulin homeostasis, particularly in the context of stress during critical periods of development, therefore these findings provide motivation for further research studies and also therapeutic approaches targeting WFS1 as a treatment for stress-related metabolic disorders in later life. This evidence concerns the gene INS and metabolic disease.